• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性或持续性子宫和宫颈恶性肿瘤的盆腔扩大切除术:盒外手术的最新进展。

Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: an update on out of the box surgery.

机构信息

Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

出版信息

Gynecol Oncol. 2012 May;125(2):404-8. doi: 10.1016/j.ygyno.2012.01.031. Epub 2012 Jan 28.

DOI:10.1016/j.ygyno.2012.01.031
PMID:22285844
Abstract

OBJECTIVE

To update our report on the outcome of patients who underwent extended pelvic resection (EPR) for recurrent or persistent uterine and cervical malignancies.

METHODS

We reviewed the records of all patients who underwent EPR between 6/2000 and 07/2011. EPR was defined as an en-bloc resection of a pelvic tumor with sidewall muscle, bone, major nerve, and/or major vascular structure. Complications up to 180 days post surgery were analyzed. Survivals were estimated using the Kaplan-Meier method.

RESULTS

We identified 22 patients. Median age at the time of EPR was 58 years (range, 36-74). Median tumor diameter was 5.4 cm (range, 1.5-11.2). Primary tumor sites included: uterus, 13; cervix, 7; synchronous uterus/cervix, 1; and synchronous uterus/ovary, 1. The EPR structures were: muscle, 13; nerve, 10; bone, 8; vessel, 5. Complete gross resection with microscopically negative margins (R0 resection) was achieved in 17 patients (77%). There were no perioperative mortalities. Major postoperative complications occurred in 14 patients (64%). The two most common morbidities were pelvic abscesses and peripheral neuropathies. Median follow-up time was 28 months (range, 6-99). The 5-year overall survival (OS) for the entire cohort was 34% (95% CI, 13-57). For the 17 patients who had an R0 resection, the 5-year OS was 48% (95% CI, 19-73). In patients with positive pathologic margins (n=5), the 5-year OS was 0%.

CONCLUSION

EPR was associated with prolonged survival when an R0 resection was achieved. The high rate of postoperative complications remains a hallmark of these procedures and properly selected patients should be extensively counseled preoperatively.

摘要

目的

更新我们对接受广泛盆腔切除术(EPR)治疗复发性或持续性子宫和宫颈恶性肿瘤患者的结果报告。

方法

我们回顾了 2000 年 6 月至 2011 年 7 月期间接受 EPR 的所有患者的病历。EPR 定义为整块切除骨盆肿瘤及其侧壁肌肉、骨骼、主要神经和/或主要血管结构。分析术后 180 天内的并发症。使用 Kaplan-Meier 法估计存活率。

结果

我们共确定了 22 名患者。EPR 时的中位年龄为 58 岁(范围,36-74 岁)。肿瘤直径的中位数为 5.4cm(范围,1.5-11.2cm)。原发肿瘤部位包括:子宫 13 例;宫颈 7 例;子宫/宫颈同步 1 例;子宫/卵巢同步 1 例。EPR 结构包括:肌肉 13 例;神经 10 例;骨骼 8 例;血管 5 例。17 名患者(77%)实现了大体完全切除且显微镜下无肿瘤边缘(R0 切除)。无围手术期死亡。14 名患者(64%)发生重大术后并发症。最常见的两种并发症是盆腔脓肿和周围神经病。中位随访时间为 28 个月(范围,6-99 个月)。整个队列的 5 年总生存率(OS)为 34%(95%CI,13-57)。在 17 名获得 R0 切除的患者中,5 年 OS 为 48%(95%CI,19-73)。在病理切缘阳性的患者(n=5)中,5 年 OS 为 0%。

结论

当实现 R0 切除时,EPR 与延长生存时间相关。高术后并发症发生率仍然是这些手术的一个特点,应在术前对适当选择的患者进行充分的咨询。

相似文献

1
Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: an update on out of the box surgery.复发性或持续性子宫和宫颈恶性肿瘤的盆腔扩大切除术:盒外手术的最新进展。
Gynecol Oncol. 2012 May;125(2):404-8. doi: 10.1016/j.ygyno.2012.01.031. Epub 2012 Jan 28.
2
Pelvic exenteration with curative intent for recurrent uterine malignancies.有治愈意图的盆腔廓清术治疗复发性子宫恶性肿瘤。
Gynecol Oncol. 2012 Jan;124(1):42-7. doi: 10.1016/j.ygyno.2011.09.031. Epub 2011 Oct 20.
3
Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcome.广泛性盆腔脏器切除术联合全阴道切除术治疗复发性或持续性泌尿生殖系统恶性肿瘤:手术技术、并发症及预后的综述。
Gynecol Oncol. 2012 Sep;126(3):346-50. doi: 10.1016/j.ygyno.2012.04.034. Epub 2012 Apr 30.
4
Surgical salvage of recurrent rectal cancer after transanal excision.经肛门切除术后复发性直肠癌的手术挽救治疗。
Dis Colon Rectum. 2005 Jun;48(6):1169-75. doi: 10.1007/s10350-004-0930-3.
5
Indications for primary and secondary exenterations in patients with cervical cancer.宫颈癌患者原发和继发眼眶内容剜除术的适应症。
Gynecol Oncol. 2006 Dec;103(3):1023-30. doi: 10.1016/j.ygyno.2006.06.027. Epub 2006 Aug 4.
6
Out-of-the-box pelvic surgery including iliopsoas resection for recurrent gynecological malignancies: Does that make sense? A single-institution case-series.针对复发性妇科恶性肿瘤的开创性盆腔手术,包括髂腰肌切除术:这有意义吗?一项单机构病例系列研究。
Eur J Surg Oncol. 2017 Apr;43(4):710-716. doi: 10.1016/j.ejso.2016.10.028. Epub 2016 Nov 17.
7
Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery.复发性子宫癌和宫颈癌的扩大盆腔切除术:突破常规的手术
Int J Gynecol Cancer. 2008 Sep-Oct;18(5):1139-44. doi: 10.1111/j.1525-1438.2007.01140.x. Epub 2007 Dec 5.
8
Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies.晚期妇科恶性肿瘤患者盆腔廓清术的长期临床结局。
J Surg Oncol. 2010 May 1;101(6):507-12. doi: 10.1002/jso.21518.
9
Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer.282 例晚期或复发性宫颈癌盆腔廓清术患者的适应证及长期临床结局。
Gynecol Oncol. 2012 Jun;125(3):604-9. doi: 10.1016/j.ygyno.2012.03.001. Epub 2012 Mar 7.
10
Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.晚期或复发性妇科癌症多学科挽救性手术后长期生存的预测因素。
J Surg Oncol. 2007 May 1;95(6):476-84. doi: 10.1002/jso.20686.

引用本文的文献

1
Five-year quality-of-life assessment by urinary diversion type after pelvic Exenterations.盆腔脏器清除术后按尿流改道类型进行的五年生活质量评估。
Gynecol Oncol. 2024 Dec;191:212-218. doi: 10.1016/j.ygyno.2024.10.016. Epub 2024 Oct 22.
2
Vascular resection and reconstruction in recurrent granulosa cell tumor.复发性颗粒细胞瘤的血管切除与重建
Gynecol Oncol Rep. 2024 Aug 31;55:101496. doi: 10.1016/j.gore.2024.101496. eCollection 2024 Oct.
3
Robotic-Assisted Pelvic Exenteration for Cervical Cancer: A Systematic Review and Novel Insights into Compartment-Based Imaging.
机器人辅助宫颈癌盆腔脏器清除术:一项系统评价及基于分区成像的新见解
J Clin Med. 2024 Jun 24;13(13):3673. doi: 10.3390/jcm13133673.
4
Quality of Life After Extended Pelvic Surgery with Neurovascular or Bony Resections in Gynecological Oncology: A Systematic Review.妇科肿瘤学中进行神经血管或骨切除的扩大盆腔手术后的生活质量:一项系统评价
Ann Surg Oncol. 2024 May;31(5):3280-3299. doi: 10.1245/s10434-023-14649-z. Epub 2024 Mar 8.
5
The Role of Pelvic Exenteration in Cervical Cancer: A Review of the Literature.盆腔脏器切除术在宫颈癌中的作用:文献综述
Cancers (Basel). 2024 Feb 18;16(4):817. doi: 10.3390/cancers16040817.
6
Long-term outcomes of pelvic exenterations for gynecological malignancies: a single-center retrospective cohort study.妇科恶性肿瘤盆腔廓清术的长期结果:单中心回顾性队列研究。
BMC Cancer. 2024 Jan 17;24(1):88. doi: 10.1186/s12885-024-11836-3.
7
Outcomes of Ureteroneocystostomy in Patients With Cancer.输尿管-膀胱再吻合术治疗癌症患者的结果。
Urology. 2021 Dec;158:131-134. doi: 10.1016/j.urology.2021.08.032. Epub 2021 Sep 6.
8
The role of imaging in pelvic exenteration for gynecological cancers.影像学在妇科癌症盆腔廓清术的作用。
Br J Radiol. 2021 Sep 1;94(1125):20201460. doi: 10.1259/bjr.20201460. Epub 2021 May 7.
9
Selection of Treatment Regimens for Recurrent Cervical Cancer.复发性宫颈癌治疗方案的选择
Front Oncol. 2021 Feb 2;11:618485. doi: 10.3389/fonc.2021.618485. eCollection 2021.
10
Is a Vaginectomy Enough or is a Pelvic Exenteration Always Required for Surgical Treatment of Recurrent Cervical Cancer? A Propensity-Matched Study.根治性子宫切除术足够,还是复发宫颈癌的手术治疗总是需要盆腔脏器切除术?一项倾向评分匹配研究。
Ann Surg Oncol. 2021 Jun;28(6):3281-3290. doi: 10.1245/s10434-020-09207-w. Epub 2020 Oct 15.